Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
2Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Raphael Pharmaceutical Inc. (RAPH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
9Total relationships
3Distinct source URLs
6High confidence
0.822Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Raphael Pharmaceutical Inc. Suppliers
Ticker
Name
Confidence
Evidence
RAMBAM
RAMBAM
92%
On July 17, 2019, we entered into a sponsored Research Agreement with Rambam, pursuant to which the Company agreed to fund a research project, to be performed by Rambam
WOLC
WOLC
92%
Wolc will be the exclusive supplier of any approved pharmaceutical drug products of the Company in Israel.
ct to the receipt of regulatory approval to commercialize our pharmaceutical product candidates, our goal is to distribute our approved formulas to good manufacturing practice, or GMP, approved medic…
Reciprocal relationship from ORANY graph: Reciprocal relationship from RAPH graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from RAPH graph: ct to the receipt of regulatory a…
Reciprocal relationship from CLM graph: Alias reverse search [Cornerstone]: RAPH 10-K (2026-03-31) mentions 'Cornerstone' in customer context. Excerpt: various cannabinoid receptors and determine the…
OTC-MARKETS-GROUP-INC
OTC-MARKETS-GROUP-INC
62%
g other things, refusal to approve a pending application for a new drug product, withdrawal of an approval or suspension of production. As a result, our business, financial condition and results of o…
Raphael Pharmaceutical Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
RAPH-DEBT-12050
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
RAPH-DEBT-12049
Warrants outstanding: 1000000
90%
xbrl warrant detail from xbrl 2025-12-31.
RAPH-DEBT
Debt stack $41,000
90%
Market cache reports total debt of $41,000.
Raphael Pharmaceutical Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Raphael Pharmaceutical Inc..
Raphael Pharmaceutical Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Raphael Pharmaceutical Inc..
Raphael Pharmaceutical Inc. Extended Supply Chain Network
